| Market Cap | ₹5,578Cr |
| ROE | 8.26% |
| P/E Ratio(TTM) | 78.19 |
| EPS(TTM) | 7.11 |
| P/B Ratio | 5.14 |
| Dividend Yield | 0.00% |
| Industry P/E | 56.91 |
| Book Value | 108.20 |
| Debt to Equity | 0.36 |
| Face Value | 2 |
| Managing Director | Dr. Pratim Sengupta |
| Founded | 2014 |
| NSE Symbol | NEPHROPLUS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | NA (0.00%) | 58.66 | ||
| Max Healthcare Institute | NA (0.00%) | 73.76 | ||
| Fortis Healthcare | NA (0.00%) | 70.48 | ||
| Narayana Hrudayalaya | NA (0.00%) | 48.17 |